Clinical trials: AdV Infection

ADV Infection Post Allo-HSCT

Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT

• Completed
• Age: Up to 16 years
• Phase 1/2
• Injection or infusion

Human Adenovirus-specific T-cells can persist and augment impaired adenovirus immune response post allogeneic haematopoietic stem cell transplant, and reduce the requirement for antiviral therapy without toxicity or increasing…

Trial name

ASPIRE (NCT01822093)

Testing

Cytovir-ADV

Where

3 sites in United Kingdom

Volunteers

8 people, healthy volunteers welcome

Sponsor

Cell Medica Ltd